Patients self-administer the drug using a pre-dosed injector pen, but Lilly recently introduced the product in single-dose ...
Eli Lilly And Co (NYSE:LLY) announced a $3 billion expansion of its Kenosha County, Wisconsin, manufacturing facility to ...
Indianapolis-based Eli Lilly's expansion into Bristol will focus on manufacturing injectable medications, device assembly and ...
SIGN UP TO CONTINUEPrint Subscriber? Sign Up for Full Access!Please sign up for as low as 36 cents per day to continue viewing our website.Digital subscribers receiveUnlimited access to all stories ...
Per Lilly, this is its single-largest manufacturing investment in the country outside its home state. It plans to start ...
The purchase price of the facility was not disclosed, but Lilly says its new $3 billion investment – part of $23 billion ...
The expansion of a newly acquired facility in Wisconsin is Lilly’s largest U.S. manufacturing investment outside of Indiana ...
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.
The top China executive of US pharmaceutical company Eli Lilly and Co said on Wednesday that the company aims to make its ...
Eli Lilly and Company LLY announced earlier this week that its popular obesity drug, Zepbound (tirzepatide) outperformed ...
The billionaire recently bought an obesity drug stock that could soar nearly 20% over the next 12 months, according to Wall ...
As the project moves forward here is some basic information about the company and the proposed $3 billion development itself.